What Biohackers Know About mTOR That You Don't?
28 Feb 2025 · 1 min

1:11
In this monologue, the speaker explains the mammalian target of rapamycin (mTOR) as a central growth-promoting pathway activated by protein, insulin, and glucose, which supports muscle building but can accelerate cellular aging when over‑stimulated. The speaker describes how fasting reduces nutrient availability, thereby suppressing mTOR activity and shifting cells toward maintenance and repair rather than division. Finally, the speaker discusses the supplement “Mimeo,” clarifying that it does not directly down‑regulate mTOR but instead up‑regulates complementary pathways—namely NAD⁺ synthesis, AMPK activation, and PPAR‑α signaling—that counteract mTOR‑driven growth and are typically dormant during high‑nutrient states.










